Fulcrum Therapeutics Inc. Common Stock (FULC)
Stock · NASDAQ · Health Care
$3.66as of 10/16/2026
Price chart
Active signals
FULC Signal Track Record
How signals performed across all stocks →What FULC's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 40 | +5.0% | 57% | September 18, 2026 |
| Bollinger Band Breakout | 25 | +5.8% | 56% | August 7, 2026 |
| Bollinger Band Breakdown | 16 | -2.3% | 44% | September 28, 2026 |
| Any 20-session window (baseline) | +1.9% | 53% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About FULC
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its clinical-stage product candidate is pociredir, a fetal hemoglobin inducer, which is in phase 1b clinical trial for the treatment of sickle cell disease and beta-thalassemia. The company also…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 9
- Website
- www.fulcrumtx.com/
Fundamentals
- 1-day range
- $3.66$3.73
- Market cap
- $287.64M
- P/E (trailing)
- —
- P/E (forward)
- -6.70
- EPS (trailing)
- $-0.90
- Dividend yield
- —
- Beta
- 2.79
- Avg. volume
- 1.56M
How Fulcrum Therapeutics Inc. Common Stock Makes Money
Where the revenue actually goes — FY2024 annual results
Source: 10-K filed Feb 25, 2025 · via SEC EDGAR / Finnhub
Forecasts
3 analyst ratings
Fulcrum Therapeutics Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- FULCFulcrum Therapeutics Inc. Common Stock$3.65▼ 0.54%Market cap $287.64MP/E —$2.83$15.74
- IMRXImmuneering Corporation Class A Common Stock$3.59▼ 1.37%Market cap $288.55MP/E —$3.6$8.48
- TTRXTurn Therapeutics Inc. Common Stock$10.57▼ 8.80%Market cap $286.26MP/E —$2.57$26.5
- ALXOALX Oncology Holdings Inc. Common Stock$1.06▲ 6.00%Market cap $283.93MP/E —$0.8617$2.66
- CAMPCAMP4 Therapeutics Corporation Common Stock$3.17▼ 8.12%Market cap $282.25MP/E —$2.86$7.75
- BCYCBicycle Therapeutics plc American Depositary Shares$3.46▼ 3.89%Market cap $277.87MP/E —$3.33$9.08
- AMRNAmarin Corporation plc$11.32▼ 2.16%Market cap $301.21MP/E —$11.34$20.9
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| FULC Fulcrum Therapeutics Inc. Common Stock | $287.64M | — | $3.65 | ▼ 0.54% | $2.83$15.74 |
| IMRX Immuneering Corporation Class A Common Stock | $288.55M | — | $3.59 | ▼ 1.37% | $3.6$8.48 |
| TTRX Turn Therapeutics Inc. Common Stock | $286.26M | — | $10.57 | ▼ 8.80% | $2.57$26.5 |
| ALXO ALX Oncology Holdings Inc. Common Stock | $283.93M | — | $1.06 | ▲ 6.00% | $0.8617$2.66 |
| CAMP CAMP4 Therapeutics Corporation Common Stock | $282.25M | — | $3.17 | ▼ 8.12% | $2.86$7.75 |
| BCYC Bicycle Therapeutics plc American Depositary Shares | $277.87M | — | $3.46 | ▼ 3.89% | $3.33$9.08 |
| AMRN Amarin Corporation plc | $301.21M | — | $11.32 | ▼ 2.16% | $11.34$20.9 |
P/E shows — for peers not currently carrying a live signal of their own.
Insider Activity
Insider Actions →- TANG KEVIN · July 17, 2026 · Buy50.9K @ $3.52
- TANG KEVIN · July 16, 2026 · Buy116.7K @ $3.56
- TANG KEVIN · July 15, 2026 · Buy107.4K @ $3.56
- TANG KEVIN · July 14, 2026 · Buy53.7K @ $3.56
- TANG KEVIN · July 14, 2026 · Buy76.0K @ $3.58
- TANG KEVIN · July 13, 2026 · Buy13.0K @ $3.54
- Banks Sonja · June 30, 2026 · Grant32.0K
- Alan Ezekowitz · June 30, 2026 · Grant32.0K
- Hill Colin · June 30, 2026 · Grant32.0K
- Haviland Kate · June 30, 2026 · Grant32.0K
- Dorton Katina · June 30, 2026 · Grant32.0K
- King Rachel K. · June 30, 2026 · Grant32.0K
- Robert J. Gould · June 30, 2026 · Grant32.0K
- GERAGHTY JAMES A · June 30, 2026 · Grant32.0K
- Lehrer-Graiwer Joshua · April 23, 2026 · Grant64.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 71.41M
- Total value held
- $538.04M
- Institutional holders
- 163
- Unknown6.56M
- Unknown6.05M
- Unknown5.39M
- Unknown5.25M
- Unknown3.13M
- Unknown3.05M
- Unknown2.69M
- Unknown2.35M
- Unknown2.26M
- Unknown2.21M
See the full, filterable feed with live charts on the MarketWall dashboard.